Collaborative Drug Therapy Management (CDTM)Collaborative Drug Therapy Management (CDTM) offers a valuable opportunity for pharmacists to work directly with physicians in managing and optimizing drug therapies for patients. Under CDTM, pharmacists can adjust or manage medication regimens for specific diseases or conditions, provided the patient consents and the practice occurs in facilities regulated by Article 28 of the Public Health Law, such as diagnostic centers, treatment centers, and hospital-based outpatient departments. The successful implementation of CDTM across New York has led to notable improvements in patient care outcomes, medication adherence, and reductions in healthcare costs. The authority for CDTM has been renewed for another two years as of July 2024, as it is necessary to ensure the continued availability of these essential services. It is crucial to communicate to your legislators the importance of maintaining and supporting CDTM to be signed into law. Frequent renewal requirements can hinder the growth and stability of these valuable services, potentially impacting patient care and healthcare efficiency. Please consider reaching out to your legislators to advocate for the continued support and robust development of CDTM services. Your support helps ensure that these critical resources remain available for improving patient care across New York. Consent With the rise of telehealth, the requirement that patients provide consent in writing has been challenging for some. The NYS Department of Health and Department of Education released guidance stating this consent may be made with the use of an electronic signature. Click HERE to review. Collaborative Drug Therapy Management (CDTM) August 2023: Pharmacist Incident-to Billing in Medicare - New! Click HERE to check out this short video made by Lilia Davenport and others from the NYSCHP Advocacy Chapter on CDTM! CDTM Example Documents:
Development of a CDTM Practice Scope of Practice Advancement NYSCHP believes that pharmacists should be able to practice at the top of their license. Unfortunately, state and federal laws/regulations restrict the care pharmacists are able to provide. ASHP, in collaboration with other national pharmacy groups and state affiliates like NYSCHP, submitted extensive recommendations to CMS regarding the elimination of regulations that limit pharmacists from practicing at the top of their license. CMS requested additional input and recommendations under the Oct. 3, 2019, Executive Order “Protecting and Improving Medicare for Our Nation’s Seniors.” Comments to CMS regarding optimizing scope of practice for Pharmacists |